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720a Wednesday, February 19, 2014either detectable changes in [Ca2þ]i or in barrier function which pointed to
a complex role of Ca2þ signaling, if any, in endothelial barrier regulation.
Absent or inconsistent [Ca2þ]i transients under conditions of increased cellular
confluency further challenge a role of Ca2þ-mediated signaling in receptor-
mediated disruption of barrier integrity. A thorough pharmacological examina-
tion revealed that different SOC inhibitors (e.g. lanthanides, 2-APB, BTP2)
completely abrogated store-operated calcium entry (SOCE) while having no
effect on receptor-mediated disruption of endothelial barrier function thus
suugesting that SOCE is not required for endothelial barrier regulation.
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The combination of human induced pluripotent stem cell-differentiated cardi-
omyocytes (hiPSC-CMs) with multi-electrode array (MEA) technology allows
for a medium throughput assessment of cardiovascular risk at preclinical stages
of drug discovery well in advance of candidate selection. Field potential dura-
tion (FPD) is a surrogate marker for QT duration and, like QT duration, is beat
rate-dependent. Correction for changes in rate is required to properly interpret
direct effects on FPD or QT. The FPD is defined as the time interval between
initiation of the fast (Naþ spike) voltage deflection due to INa and subsidence of
the slow, positive deflection due to repolarizing IK currents, and is a biomarker
for QT duration. Our data demonstrate that FPD is highly correlated with
the beat period in a largely non-linear fashion. Additionally, non-paced
hiPSC-CMs are susceptible to dramatic drug-induced beat period changes.
Consequently, interpretation of the effects of drugs on these parameters
requires a beating rate correction. However, commonly used human ECG-
derived QT correction formulae (e.g. Fredericia’s, Bazett’s) prove inadequate
outside a narrow range of FPD-beat period linearity. Their use may incorrectly
classify QT/FPD modifying compounds. We therefore developed and qualified
a set of algorithms for FPD:beat period correction based on the response of
hiPSC-CMs to the If inhibitor ZD7288 and the beta adrenergic agonist isopro-
terenol. The resulting FPD:beat period relationship had a limited linear range
and an extended non-linear range. These algorithms were compared to other
common correction methods. We found that individual correction provided a
statistically significantly improvement over classical correction formulae
(on parameters of linearity & slope) in the non-linear range. This correction
algorithm has been incorporated into our MEA assay for QT risk assessment.
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Blockade of the human ether-a-go-go-related gene (hERG) ion channel is a
marker for pro-arrhythmic risk. However, the extent of hERG channel inhibi-
tion is poorly correlated with action potential duration (APD) prolongation in
vitro, due to multi-channel block. Subsequently, compounds which block mul-
tiple ion channels may be overlooked by pre-clinical safety screening when
measuring voltage alone, with the potential risk of late stage drug attrition
and withdrawal. In this work we propose optical measurements of voltage
and intracellular calcium ([Ca2þ]i) in hiPSC-CMs as an alternative to the cur-
rent drug screening methods to distinguish mixed action drugs in early stages.
We used hiPSC-CMs loaded with 3mM di-4-ANEPPS to record membrane po-
tential and 1mM Fura 4-AM to measure [Ca2þ]i from areas of iPSCs using Cel-
lOPTIQ platform (Clyde Biosciences, Glasgow UK). Fluorescence signals
were digitized at 10kHz and analyzed off-line using proprietary software.
Mixed ion channel blockade was mimicked by the co-administration of E-
4031 (hERG blocker) and Nifedipine (Ca2þ channel blocker). The results
showed that at a critical combined concentrations (e.g. 30nM E4031 þ
30nM Nifedipine) which individually prolonged and shortened APD at 75%
of repolarisation (APD75) respectively, in combination did not significantly
change APD75 from baseline (APD75 6.5 5 7% of control), whereas[Ca2þ]i was markedly reduced (by 18 5 1.2% change, p<0.05). Low con-
centrations of Verapamil (30nM), an antiarrhythmic drug with known mixed
hERG and L-type Ca2þ channel activity, had no significant effect on APD
(APD75 1.5 5 0.7%) whereas the amplitude of Ca2þ transient was signifi-
cantly reduced (by 455 8%, p<0.05). In conclusion, simultaneous measure-
ments of [Ca2þ]i and voltage provides a convenient indicator of mixed ion
channel effects when screening for drug-induced cardiotoxicity.
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Heart-related health problems remain a leading cause of mortality in developed
countries. To efficiently fight these problems, cardiology needs an information-
rich screening for new drug candidates. Recent achievements in stem cell
research provide a long-awaited solution by producing human stem-cell
derived cardiomyocytes and, thus, providing various "disease-in-a-dish"
models of cardiac disorders.
Two biologically distinct parameters are required to efficiently characterize the
cardiomyocytes function: changes in cell membrane potential and distribution
of intracellular calcium ions. Unfortunately, due to experimental limitations
and lack of appropriate fluorescent indicators, the traditional approach to
perform such an assessment is to record one signal at a time.
Here we present novel approach to perform multi-parametric assessment of
cardiomyocytes while using two functionally different fluorescent indicators
excited by the same wavelength of light. Specifically, using the IC200 HCS
screening system (Vala Sciences), we performed a functional assessment of
stem cell-derived cardiomyocytes by parallel optical recording of two physio-
logically distinct signals in real time: dynamic changes in cell membrane
voltage as well as redistribution of calcium ions in cells. To do that, in addition
to a calcium indicator Fluo4, we used a novel highly efficient voltage-sensitive
fluorescent dye (VF 2.1) to detect voltage changes in cardiomyocytes.
To perform data analysis, we have developed a dedicated software program that
by creating spatially distinct subsets of masks is separating calcium and voltage
signals. Using our multiparametric assay, we have performed several screening
campaigns using benchmark compounds such as modulators of ion channels
involved in generation of cardiac action potential (hERG channels, sodium
and calcium voltage-gated ion channels), as well as drugs that affect the intra-
cellular calcium handling. In summary, we have developed a multi-parametric
approach for comprehensive screening of a human stem cell-derived cardio-
myocytes for drug discovery and cardiotoxicity purposes.
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Drug-induced cardiac arrhythmias characterized by QT prolongation have been
a major reason for drug withdrawal at late stage of clinical trials. Species dif-
ference is a cause of insufficient predictability of current drug safety models.
Therefore, human induced pluripotent stem cell-derived cardiomyocytes
(hiPS-CMs) have great promise for application of cardiac drug safety testing
as a human cardiac model. Our perforated patch-clamp recordings from
hiPS-CMs revealed that the cells exhibited diverse shapes of spontaneous
action potentials (APs) with relatively small upstroke velocity (~10V/s) and
depolarized maximum diastolic potential (MDP; >-50 mV), which represents
rather immature forms of cardiac cells. Actually, a selective hERG blocker,
E4031,depolarized significantly MDP and stopped spontaneous beatings on a
monolayer of hiPS-CMs, which makes it difficult to evaluate the effects on
AP durations.Thus, in order to improve evaluation of risks for drug-induced
QT prolongation in hiPS-CMs, we generated ventricular-like hiPS-CMs by
over-expressing protein-X into hiPS-CMs and characterized the utility for eval-
uation of drug effects on cardiac repolarization process. The protein-X over-
expression made hiPS-CMs quiescent with hyperpolarized MDP (67 mV),
and were excitable with rapid upstroke velocity (~95 V/s) by electrical field
stimulation. When E4031 was applied to hiPS-CMs overexpressing protein-
X, both AP durations of single myocytes and extracellular field potential
durations of cardiac sheets were prolonged in a dose dependent manner. These
results suggest that hiPS-CMs engineered with gene X would be a novel
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in the human cardiomyocytes.
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We have previously shown that reducing Naþ influx by a reduction in peak Naþ
current (INa,peak) in isolated cardiac myocytes leads to a decrease in pro-
arrhythmic Ca2þ waves. However, INa,peak inhibition can result in reduced
conduction velocity and promote wavebreak leading to enhanced arrhythmia
in vivo. Here we test if ranolazine, an inhibitor of late Naþ current (INa,late)
could also reduce the occurrence of Ca2þ waves without potentially problem-
atic reductions in INa,peak. Cells, loaded with fluo-4AM to monitor intracellular
Ca2þ, were stimulated at different pacing rates followed by a one-minute rest
period for wave detection.
10mM ranolazine reduced Ca2þ wave frequency in cells following pacing at
5Hz although less potently than 5mM flecainide (0.1350.02 waves.s1 (flecai-
nide) vs 0.1650.02 waves.s1 (ranolazine), P<0.01). Comparable effects were
achieved when the concentration of ranolazine was increased to 20mM
(0.1450.02 waves.s1 (flecainide) and 0.1850.03 waves.s1 (ranolazine) vs
0.2250.03 waves.s1 (control), P<0.001 and 0.05 respectively) although at
this concentration there is a significant reduction in INa,peak. Ranolazine’s
ability to reduce wave occurrence was tested further under two conditions in
which enhancement of INa,late, would be expected; in the presence of anemone
toxin II and in cells from an established model of chronic heart failure (HF). In
both conditions wave frequency was increased (e.g. 0.0850.01 waves.s1 (HF)
vs 0.0650.01 waves.s1 (control), P<0.05) but ranolazine was not effective at
reducing frequency (0.1950.04 waves.s1 (ranolazine 10mM) vs 0.1950.04
waves.s1 (control), P=0.92).
Ranolazine decreased Ca2þ wave frequency in isolated cardiomyocytes, partic-
ularly at concentrations where INa,peak is reduced. The lack of efficacy in states
of enhanced INa,late suggests specific effects of the drug are less important than
off-target effects on INa,peak. Thus similar dose-limiting side effects as with
conventional INa blockers are expected.
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Development of in vitro toxicity assays based on the human stem cell-derived
cardiomyocytes (SC-CMs) provides an opportunity to assess the specific car-
diac safety end-points early in drug development. The cardiac action potential
(AP) is an established biomarker for cardiac safety and efficacy in humans and
a good detector of proarrhythmic events. However, its utility has been mainly
limited by a low throughput of manual patch clamp and a restricted access
to healthy human cardiomyocytes. The recent progress in automated electro-
physiology combined with availability of human SC-CMs provides an exciting
possibility to measure AP in human cells expressing endogenous cardiac ion
channels.
Electrophysiological properties of human SC-CMs were investigated with spe-
cial focus on establishment of automated cell-based cardiac safety screens.
For the first time assay protocols and procedures were established to measure
and characterize both cardiac AP and the main underlying currents in human
SC-CMs using automated electrophysiology platforms Patchliner(r) and
Synchropatch(r)96 (Nanion Technologies GmbH). Employment of the higher
throughput systems allowed capturing and evaluating AP and cardiac current
profiles in cardiomyocyte cultures revealing specific heterogeneity. Outward
potassium current mainly consisting of slow and rapid delayed rectifier and
Ca2þ-activated components as well as inward cardiac sodium current were
recorded and characterized. Density of L-type Ca2þ current varied with the
type and differentiation status of cardiomyocytes. The inward rectifier potas-
sium current and a pacemaker current could also be measured. These results
demonstrate that functional cardiac currents and appropriate AP present in
human SC-CMs can be successfully recorded by automated electrophysiology
systems.
The automated cardiac AP measurements in human SC-CMs exemplify a novel
screening method for early and sensitive detection of multiple ion channel
effects in vitro completing the current core battery hERG assay and animal
ECG measurements in pre-clinical safety assessment.3653-Pos Board B381
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Auditory stimuli are a recognized trigger of arousal-induced torsade de pointes
(TdP) in patients with Long QT Syndrome Type 2 (LQT2). There is also clear
evidence that the effect of auditory stimulation to modulate ventricular repolar-
ization is more pronounced in women than men, and that female sex is an
independent risk factor for long-QT syndrome and increased propensity for
torsade de pointes arrhythmias. Indeed, females with LQT2 experience a
greater than nine-fold increase in the risk for arousal-triggered cardiac events
compared with men in the same age group after the onset of adolescence. In
order to reveal the interactions and contributions of rapid bursts of sympathetic
activity, sex steroid hormones and differences in ion channels expression in
male and female hearts, we have developed a model of the female cardiac
cell that includes sex stereoid hormones and experimentally observed reduction
in expression of Connexin 43 (Cx43) and repolarization currents IK1, IKr, IKs,
and Ito compared to males. These changes were incorporated into the
O’Hara-Rudy human ventricular cell model. In order to account for sympathet-
ically mediated arousal, we also incorporated subcellular signaling pathways
linked to beta-adrenergic receptors. Finally, Long-QT 2 mutations were incor-
porated into the model. The model simulations predict that the high estrogen
levels and low progesterone levels that occur during the follicular phase of
the menstrual cycle in females and the interplay between larger net inward
currents set the stage for action potential prolongation that in combination
with sudden bursts of beta-adrenergic signaling leads to a profoundly increased
likelihood of arrhythmia triggers in females compared to males in singe cells
and 1-D tissue. The model also predicts a high degree of protection by testos-
terone in males against arrhythmia triggering.
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It is well known that extracellular calcium concentration ([Ca2þ]o) affects
cardiac action potential duration (APD): their inverse relationship has been
experimentally observed in vivo and in vitro. Both shortening and prolongation
of action potential (AP) are associated with an increased risk of arrhythmias
and extracellular calcium variations may occur in many clinical contexts.
Computational modeling could be a useful tool to explore this phenomenon:
however, most of the commonly used ventricular cell models are not able
to reproduce [Ca2þ]o effects on AP duration properly, i.e. they respond
to [Ca2þ]o increase with AP prolongation. The aim of this study has been to
modify the most recent human ventricular AP model, in order to improve its
response to [Ca2þ]o variations.
The O’Hara-Rudy AP model (ORd) has been used as basis. Its L-type calcium
current formulation has been replaced by a novel Markov model. Calcium-
dependent inactivation (CDI) has been strengthened, with respect to the
Voltage-dependent one (VDI). All inactivation rates are actually voltage-
dependent: Ca2þ modulates only the fraction of channels working in CDI
mode, which is 10 times faster than the VDI. After few minor changes, all
involving Ca2þ-handling, the modified model has been validated against a
wide set of experimental data. Simulations were run with the original and
modified models considering [Ca2þ]o ranging from 1 to 3 mM.
In control ([Ca2þ]o =1.8mM), the modified and original ORd model APs and
ionic currents were very similar. However, when changing [Ca2þ]o from 0.9
to 2.7 mM, APDs varied in an opposite way: þ19% vs 12%, original and
modified models respectively. Therefore, the modified model may be used to
explore in silico electrolyte changes effects on AP. Moreover, these results
suggest that CDI mechanism is usually underestimated in ventricular human
AP models.
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The property of human induced pluripotent stem cell-derived cardiomyocytes
(hiPSC-CMs) to carry the same genetic mutations of the patient’s cardiomyo-
cytes, made them promising in-vitro patient-specific disease cell models.
